Business
Results of AGM
Results of AGM.
About this update from Coiled Therapeutics Plc
[{"type":"text","content":"\n\n26 June 2025\nRoquefort Therapeutics plc\n(\"Roquefort Therapeutics\" or the \"Company\")\n \nResults of AGM\n \nRoquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company focused on developing first in class medicines in the high value and high growth immunology and oncology markets, is pleased to announce that at the Company's Annual General Meeting (\"AGM\") held earlier today, all resolutions proposed were duly passed.\n \nThe resolutions were put to shareholders via a poll, the results of which were as follows:\n\n\n\n\nResolution\n\n\nPoll Results\n\n\nTotal Votes Withheld*\n\n\n\n\nFor\n\n\nAgainst\n\n\nTotal Votes Cast\n\n\n\n\n1\n\n\nShares\n\n\n15,989,492\n\n\n205,120\n\n\n16,194,612\n\n\n289,738\n\n\n\n\n%\n\n\n98.73%\n\n\n1.27%\n\n\n\n\n2\n\n\nShares\n\n\n15,758,683\n\n\n432,163\n\n\n16,190,846\n\n\n293,504\n\n\n\n\n%\n\n\n97.33%\n\n\n2.67%\n\n\n\n\n3\n\n\nShares\n\n\n15,668,163\n\n\n522,683\n\n\n16,190,846\n\n\n293,504\n\n\n\n\n%\n\n\n96.77%\n\n\n3.23%\n\n\n\n\n4\n\n\nShares\n\n\n15,842,448\n\n\n352,163\n\n\n16,194,611\n\n\n289,739\n\n\n\n\n%\n\n\n97.83%\n\n\n2.17%\n\n\n\n\n5\n\n\nShares\n\n\n15,842,449\n\n\n352,163\n\n\n16,194,612\n\n\n289,738\n\n\n\n\n%\n\n\n97.83%\n\n\n2.17%\n\n\n\n\n6\n\n\nShares\n\n\n15,989,492\n\n\n205,120\n\n\n16,194,612\n\n\n289,738\n\n\n\n\n%\n\n\n98.73%\n\n\n1.27%\n\n\n\n\n7\n\n\nShares\n\n\n15,989,492\n\n\n205,120\n\n\n16,194,612\n\n\n289,738\n\n\n\n\n%\n\n\n98.73%\n\n\n1.27%\n\n\n\n\n8\n\n\nShares\n\n\n15,671,929\n\n\n522,683\n\n\n16,194,612\n\n\n289,738\n\n\n\n\n%\n\n\n96.77%\n\n\n3.23%\n\n\n\n\n9\n\n\nShares\n\n\n15,636,863\n\n\n557,749\n\n\n16,194,612\n\n\n289,738\n\n\n\n\n%\n\n\n96.56%\n\n\n3.44%\n\n\n\n\n* Votes withheld are not counted in the calculation of the proportion of votes for and against a resolution.\n \nThe total number of ordinary shares in issue on 24 June 2025, the deadline for casting votes by proxy in advance of the AGM, was 157,444,030 shares. 10.3% of voting capital was instructed in respect of the resolutions put to the AGM.\n \nEnquiries:\n\n\n\n\nRoquefort Therapeutics plc\n\n\n+44 (0)20 3918 8633\n\n\n\n\nStephen West (Chairman) / Dr Darrin Disley (Interim MD)\n\n\n\n\n\n\n\nSP Angel Corporate Finance LLP (Broker)\nDavid Hignell / Vadim Alexandre / Devik Mehta\n\n\n+44 (0) 20 3470 0470\n \n\n\n\n\nBurson Bu...